Biennial surveillance of Plasmodium falciparum anti-malarial drug resistance markers in Democratic Republic of Congo, 2017 and 2019

BACKGROUND: Because of the loss of chloroquine (CQ) effectiveness, the Democratic Republic of Congo (DRC)’s malaria treatment policy replaced CQ by sulfadoxine–pyrimethamine (SP) as first-line treatment of uncomplicated malaria in 2003, which in turn was replaced by artemisinin-based combination the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yobi, Doudou M., Kayiba, Nadine K., Mvumbi, Dieudonné M., Boreux, Raphael, Kabututu, Pius Z., Akilimali, Pierre Z., Situakibanza, Hippolyte N. T., De Mol, Patrick, Speybroeck, Niko, Mvumbi, Georges L., Hayette, Marie-Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830975/
https://www.ncbi.nlm.nih.gov/pubmed/35144535
http://dx.doi.org/10.1186/s12879-022-07112-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830975/
https://www.ncbi.nlm.nih.gov/pubmed/35144535
http://dx.doi.org/10.1186/s12879-022-07112-z

Ejemplares similares